<DOC>
	<DOC>NCT00600600</DOC>
	<brief_summary>To determine the safety, tolerance, and efficacy of Tigecycline when given daily to patients with rapidly growing mycobacterial disease (especially M.abscessus).</brief_summary>
	<brief_title>Tigecycline for Treatment of Rapidly Growing Mycobacteria</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Positive cultures for rapidly growing mycobacteria Patients who have drug resistant isolates or are intolerant of macrolides or have serious infections unresponsive to currently available drugs Adults and children 10 years of age and older Pretreatment isolate of M. avium complex available for MIC determination Available for followup appointments History of tetracycline allergy If a menstruating female, not pregnant and on adequate birth control</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>